Rockwell Medical Inc (RMTI) - Financial and Strategic SWOT Analysis Review

Rockwell Medical Inc (RMTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Rockwell Medical Inc (Rockwell) is a biopharmaceutical company that focuses on the development, manufacture and distribution of products for the treatment of chronic kidney disease, iron deficiency, end-stage renal disease, and hemodialysis. The company’s major products include Triferic, Dialysate Triferic, citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dry acid concentrate mixer, renalpure and sterilyte bicarbonate concentrate, hemodialysis concentrates, dialysis kits and ancillary products, among others. It is also investigating Triferic for peritoneal dialysis, total parenteral nutrition, cardiovascular disease and treating cancer patients with iron deficiency. The company markets products through distributors in the US and other countries. Rockwell is headquartered in Hackensack, New Jersey, the US.

Rockwell Medical Inc Key Recent Developments

Aug 19,2021: Rockwell Medical Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Aug 16,2021: Rockwell Medical Provides Second Quarter 2021 Financial and Operational Update
Jul 29,2021: Rockwell Medical to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021
May 17,2021: Rockwell Medical Provides First Quarter 2021 Financial and Operational Update
Mar 18,2021: Rockwell Medical to Report Fourth Quarter and Full Year 2020 Financial and Operating Results on March 31, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

LIST OF TABLES

Rockwell Medical Inc, Key Facts
Rockwell Medical Inc, Key Employees
Rockwell Medical Inc, Key Employee Biographies
Rockwell Medical Inc, Major Products and Services
Rockwell Medical Inc, History
Rockwell Medical Inc, Subsidiaries
Rockwell Medical Inc, Key Competitors
Rockwell Medical Inc, Ratios based on current share price
Rockwell Medical Inc, Annual Ratios
Rockwell Medical Inc, Annual Ratios (Cont...1)
Rockwell Medical Inc, Interim Ratios
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Rockwell Medical Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Rockwell Medical Inc, Performance Chart (2016 - 2020)
Rockwell Medical Inc, Ratio Charts
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Rockwell Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021